.png/:/rs=w:1209)
Create shared success by combining Celix Pharma's deep market know-how with partners' expertise in R&D and Manufacturing
Business models in generic pharmaceuticals
Acquire granted MA’s
License-in EU CTD dossiers
License-in EU CTD dossiers
Buy granted product licences in UK, with or without full a supply-chain behind it
License-in EU CTD dossiers
License-in EU CTD dossiers
License-in EU CTD dossiers
Licensing-in completed EU CTD dossiers for regulatory submissions in UK
Co-Development
License-in EU CTD dossiers
Co-Development
Partner in product development at different stages of the development process
Generic product portfolio
Celix Pharma is developing a pipeline of generic products across a range of dosage forms (OSD, Injectable, Opthalmics, Liquids) and therapeutic categories, catering to both primary and secondary care channels. Each product has a story and aims to address an unmet need within the healthcare system. The approach to product selection is grounded in the knowledge of the market and the supply chain behind each product. The portfolio has a good mix of complex specialty generics, products with limited suppliers and products which pose high technical barriers from either a development or manufacturing perspective.